Business
Cross-border fintech Airwallex raises $100M Series D extension at new valuation of $2.6B
Airwallex, the fintech company for cross-border businesses, announced today it has added $100 million more to its Series D round, bumping its valuation up to $2.6 billion. The extension was led by Greenoaks, with participation from Grok Ventures and returning investors Skip Capital and ANZi Ventures.
Co-founder and chief executive officer Jack Zhang told TechCrunch that the new funding will be used for Airwallex’s United States launch in the second quarter of this year, expand its payment coverage to new regions like the Middle East, Africa, Eastern Europe and Latin America, and add more products, including physical cards.
This latest extension brings Airwallex’s Series D round to $300 million, and total equity raised so far to $500 million. Airwallex first announced its Series D in April 2020 after raising $160 million, then another tranche that added $40 million in September 2020.
Airwallex reached unicorn valuation after its Series C in March 2019. The company was founded in Melbourne in 2015, and now has more than 600 employees across 12 offices in Australia, China, Hong Kong, the United Kingdom, Japan and the United States. In its announcement today, Airwallex said it is also hiring for more than 500 positions.
Airwallex’s products for cross-border businesses include foreign currency accounts and multi-currency debit cards with Visa, international money transfers and a suite of APIs that allow companies to do things like accept and manage international payments, and manage their foreign exchange risk.
-
Business7 days ago
TikTok Shop expands its secondhand luxury fashion offering to the UK
-
Business6 days ago
UnitedHealth says Change hackers stole health data on ‘substantial proportion of people in America’
-
Business6 days ago
Mood.camera is an iOS app that feels like using a retro analog camera
-
Business5 days ago
Tesla’s new growth plan is centered around mysterious cheaper models
-
Business4 days ago
Xaira, an AI drug discovery startup, launches with a massive $1B, says it’s ‘ready’ to start developing drugs
-
Business4 days ago
UK probes Amazon and Microsoft over AI partnerships with Mistral, Anthropic, and Inflection
-
Entertainment6 days ago
Furious Watcher fans are blasting it as ‘greedy’ over paid subscription service
-
Business5 days ago
Two widow founders launch DayNew, a social platform for people dealing with grief and trauma